These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12034 related articles for article (PubMed ID: 1066320)

  • 1. Search for anti-tumor response in a bone tumor patient with a long clinical history.
    Vanky F; Klein E; Cornain S; Bakács T; Stjernswärd J; Nilsonne U
    Int J Cancer; 1976 Sep; 18(3):282-92. PubMed ID: 1066320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host immune response in human osteosarcoma.
    McMaster JH; Ferguson RJ; Weinert CR
    Clin Orthop Relat Res; 1975 Sep; (111):76-82. PubMed ID: 1057466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
    Chang AE; Aruga A; Cameron MJ; Sondak VK; Normolle DP; Fox BA; Shu S
    J Clin Oncol; 1997 Feb; 15(2):796-807. PubMed ID: 9053507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune-status in patients with bone and soft-tissue sarcomas.
    Kotz R; Rella W; Salzer M
    Recent Results Cancer Res; 1976; (54):197-205. PubMed ID: 1070721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro immune response with clinical course of malignant neoplasia in dogs.
    Brodey RS; Fidler IJ; Bech-Nielsen S
    Am J Vet Res; 1975 Jan; 36(1):75-80. PubMed ID: 1054221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte and serum-mediated immunity in murine osteosarcoma.
    Miller CW; Fisher SJ
    J Bone Joint Surg Am; 1977 Oct; 59(7):981-3. PubMed ID: 269112
    [No Abstract]   [Full Text] [Related]  

  • 9. Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS).
    Vánky F; Klein E; Stjernswärd J; Rodriguez L; Péterffy A; Steiner L; Nilsonne U
    Int J Cancer; 1978 Dec; 22(6):679-86. PubMed ID: 309867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
    Vánky F; Klein E
    Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of virus-induced rat osteosarcoma.
    Urovitz EP; Czitrom AA; Langer F; Gross AE; Pritzker PH
    J Bone Joint Surg Am; 1976 Apr; 58(3):308-11. PubMed ID: 1063128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
    Gutterman J; Mavligit G; McBride C; Frei E; Hersh EM
    Cancer; 1973 Aug; 32(2):321-7. PubMed ID: 4722915
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R; Wybran J; Epstein W
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.
    Golub SH; Forsythe AB; Morton DL
    Int J Cancer; 1977 Jan; 19(1):18-26. PubMed ID: 137880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM; Cerni C; Micksche M
    Oncology; 1977; 34(5):229-33. PubMed ID: 917456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and postoperative studies of in vitro cell-mediated reactivity in canine osteosarcoma.
    Bech-Nielsen S; Reif JS; Brodey RS
    Am J Vet Res; 1978 Jan; 39(1):87-93. PubMed ID: 272858
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoptive transfer and specific active immunization of patients with malignant melanoma.
    Seigler H; Buckley CE; Sheppard LB; Horne BJ; Shingleton WW
    Ann N Y Acad Sci; 1976; 277(00):522-32. PubMed ID: 1069561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 602.